Gebel HM - Search Results

1

Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.

Dar W, Agarwal A, Watkins C, Gebel HM, Bray RA, Kokko KE, Pearson TC, Knechtle SJ. Dar W, et al. Among authors: gebel hm. Am J Transplant. 2011 Apr;11(4):841-7. doi: 10.1111/j.1600-6143.2011.03467.x. Am J Transplant. 2011. PMID: 21446981 Free article.

2

Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.

Gebel HM, Bray RA, Nickerson P. Gebel HM, et al. Am J Transplant. 2003 Dec;3(12):1488-500. doi: 10.1046/j.1600-6135.2003.00273.x. Am J Transplant. 2003. PMID: 14629279 Free article. No abstract available.

3

Approaches for transplanting the sensitized patient: biology versus pharmacology.

Gebel HM, Bray RA. Gebel HM, et al. Nephrol Dial Transplant. 2008 Aug;23(8):2454-7. doi: 10.1093/ndt/gfn108. Epub 2008 Mar 25. Nephrol Dial Transplant. 2008. PMID: 18364369 Review. No abstract available.

4

Strategies for human leukocyte antigen antibody detection.

Bray RA, Gebel HM. Bray RA, et al. Among authors: gebel hm. Curr Opin Organ Transplant. 2009 Aug;14(4):392-7. doi: 10.1097/mot.0b013e32832d31c7. Curr Opin Organ Transplant. 2009. PMID: 19610172 Review.

5

Technical aspects of HLA antibody testing.

Gebel HM, Liwski RS, Bray RA. Gebel HM, et al. Curr Opin Organ Transplant. 2013 Aug;18(4):455-62. doi: 10.1097/MOT.0b013e32836361f1. Curr Opin Organ Transplant. 2013. PMID: 23838651 Review.

6

Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts.

Everly MJ, Roberts M, Townsend R, Bray RA, Gebel HM. Everly MJ, et al. Among authors: gebel hm. Am J Transplant. 2018 Sep;18(9):2305-2313. doi: 10.1111/ajt.14939. Epub 2018 Jun 16. Am J Transplant. 2018. PMID: 29767445 Free article. Clinical Trial.

7

The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients.

Parsons RF, Zahid A, Bumb S, Decker H, Sullivan HC, Eun-Hyung Lee F, Badell IR, Ford ML, Larsen CP, Pearson TC, Jackson AM, Chen DF, Levine M, Kamoun M, Bray RA, Gebel HM. Parsons RF, et al. Among authors: gebel hm. Am J Transplant. 2020 Feb;20(2):573-581. doi: 10.1111/ajt.15585. Epub 2019 Oct 8. Am J Transplant. 2020. PMID: 31452332 Free PMC article.

8

Eplet mismatch imputation studies should include immunologic risk assessment.

Krummey SM, Bray RA, Gebel HM, Sullivan HC. Krummey SM, et al. Among authors: gebel hm. Am J Transplant. 2021 Oct;21(10):3500-3501. doi: 10.1111/ajt.16562. Epub 2021 Mar 30. Am J Transplant. 2021. PMID: 33728758 Free article. No abstract available.

9

Low-resolution HLA class II typing for solid organ transplantation is inadequate.

Bray RA, Gebel HM. Bray RA, et al. Among authors: gebel hm. Transplant Proc. 2001 Feb-Mar;33(1-2):500. doi: 10.1016/s0041-1345(00)02110-2. Transplant Proc. 2001. PMID: 11266926 No abstract available.

10

Transplanting the highly sensitized patient: The emory algorithm.

Bray RA, Nolen JD, Larsen C, Pearson T, Newell KA, Kokko K, Guasch A, Tso P, Mendel JB, Gebel HM. Bray RA, et al. Among authors: gebel hm. Am J Transplant. 2006 Oct;6(10):2307-15. doi: 10.1111/j.1600-6143.2006.01521.x. Epub 2006 Aug 25. Am J Transplant. 2006. PMID: 16939516 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page